MBS: NextGenPCR workflow detects omicron variant of SARS-CoV-2

Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that both in silico and bench testing confirmed that the NextGenPCR PCR reagents detected the omicron

Related Keywords

Netherlands ,Eurofins Megalab , ,Molecular Biology Systems ,Biology Systems ,Mbs ,Extgenpcr ,Ealth Press Release ,